Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 4;9(8):956.
doi: 10.3390/biomedicines9080956.

The Roles of Post-Translational Modifications in STAT3 Biological Activities and Functions

Affiliations
Review

The Roles of Post-Translational Modifications in STAT3 Biological Activities and Functions

Annachiara Tesoriere et al. Biomedicines. .

Abstract

STAT3 is an important transcription factor that regulates cell growth and proliferation by regulating gene transcription of a plethora of genes. This protein also has many roles in cancer progression and several tumors such as prostate, lung, breast, and intestine cancers that are characterized by strong STAT3-dependent transcriptional activity. This protein is post-translationally modified in different ways according to cellular context and stimulus, and the same post-translational modification can have opposite effects in different cellular models. In this review, we describe the studies performed on the main modifications affecting the activity of STAT3: phosphorylation of tyrosine 705 and serine 727; acetylation of lysine 49, 87, 601, 615, 631, 685, 707, and 709; and methylation of lysine 49, 140, and 180. The extensive results obtained by different studies demonstrate that post-translational modifications drastically change STAT3 activities and that we need further analysis to properly elucidate all the functions of this multifaceted transcription factor.

Keywords: STAT3; acetylation; methylation; phosphorylation; post-translational modifications.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic structure of STAT3 protein: STAT3 has a N-terminus domain (NTD), a coil-coiled domain (CDD), a DNA binding domain (DBD), a linker region (LD), a SH2 domain, and a transactivation domain (TAD) in the C-terminal portion of the protein. Phosphorylation, acetylation, and methylation sites are highlighted. Created with BioRender.com.
Figure 2
Figure 2
Schematic representation of IL-6/JAK/STAT3 pathway: IL-6 family members recognize their cognate transmembrane receptors and transmembrane proteins associated with the receptors trigger the activation of JAKs. Activated JAKs phosphorylate Y705 of STAT3 and pSTAT3 Y705 migrates to the nucleus. In the nucleus, STAT3 can be acetylated by p300/CBP and methylated by SET9 or by EZH2. HDAC and LSD1 inhibit AcSTAT3 and MeSTAT3, respectively. The Ras/Raf/MEK/ERK pathway determines S727 phosphorylation. Y705 and S727 are both required for mitochondrial functions of STAT3. Alternatively, unphosphorylated STAT3 (U-STAT3) can also regulate specific nuclear targets. Created with BioRender.com.
Figure 3
Figure 3
Main constructs used to investigate STAT3 phosphorylation. Created with BioRender.com.
Figure 4
Figure 4
Main constructs used to investigate STAT3 acetylation. Created with BioRender.com.
Figure 5
Figure 5
Main constructs used to investigate STAT3 methylations. Created with BioRender.com.

References

    1. Guanizo A.C., Fernando C.D., Garama D.J., Gough D.J. STAT3: A multifaceted oncoprotein. Growth Factors. 2018;36:1–14. doi: 10.1080/08977194.2018.1473393. - DOI - PubMed
    1. Zhang X., Darnell J.E., Jr. Functional importance of Stat3 tetramerization in activation of the alpha 2-macroglobulin gene. J. Biol. Chem. 2001;276:33576–33581. doi: 10.1074/jbc.M104978200. - DOI - PubMed
    1. Wang Y., Levy D.E. Comparative evolutionary genomics of the STAT family of transcription factors. JAKSTAT. 2012;1:23–33. doi: 10.4161/jkst.19418. - DOI - PMC - PubMed
    1. Avalle L., Camporeale A., Camperi A., Poli V. STAT3 in cancer: A double edged sword. Cytokine. 2017;98:42–50. doi: 10.1016/j.cyto.2017.03.018. - DOI - PubMed
    1. Johnson D.E., O’Keefe R.A., Grandis J.R. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat. Rev. Clin. Oncol. 2018;15:234–248. doi: 10.1038/nrclinonc.2018.8. - DOI - PMC - PubMed

LinkOut - more resources